Point72 Asset Management
PROK icon

Point72 Asset Management’s ProKidney PROK Stock Holding History

Point72 Asset Management’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$117K Buy
65,578
+48,491
+284% +$103K ﹤0.01% 3593
2025
Q4 		$38.3K Buy
+17,087
New +$44.9K ﹤0.01% 3801

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Point72 Asset Management's PROK Position: Q1 2026 in Review

Point72 Asset Management increased its ProKidney (PROK) stake by 284% in Q1 2026, buying an estimated $103K and bringing the position to 65,578 shares worth $117K. The position accounts for ﹤0.01% of the portfolio, ranked #3593.

Point72 Asset Management first reported a position in PROK in Q4 2025 and has held it in 2 quarters since. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • Point72 Asset Management held 65,578 shares of ProKidney worth $117K as of Q1 2026.
  • Point72 Asset Management bought 48,491 ProKidney shares in Q1 2026, an estimated $103K.
  • ProKidney made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #3593 holding.
  • Point72 Asset Management first reported a position in ProKidney in Q4 2025 and has held it in 2 quarters since.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.